Display options
Cite
Liu DZ, Sharp FR. Excitatory and Mitogenic Signaling in Cell Death, Blood-brain Barrier Breakdown, and BBB Repair after Intracerebral Hemorrhage. Transl Stroke Res. 2012;3:62-9doi: 10.1007/s12975-012-0147-z.
Liu, D. Z., & Sharp, F. R. (2012). Excitatory and Mitogenic Signaling in Cell Death, Blood-brain Barrier Breakdown, and BBB Repair after Intracerebral Hemorrhage. Translational stroke research, 362-9. https://doi.org/10.1007/s12975-012-0147-z
Liu, Da-Zhi, and Sharp, Frank R. "Excitatory and Mitogenic Signaling in Cell Death, Blood-brain Barrier Breakdown, and BBB Repair after Intracerebral Hemorrhage." Translational stroke research vol. 3 (2012): 62-9. doi: https://doi.org/10.1007/s12975-012-0147-z
Liu DZ, Sharp FR. Excitatory and Mitogenic Signaling in Cell Death, Blood-brain Barrier Breakdown, and BBB Repair after Intracerebral Hemorrhage. Transl Stroke Res. 2012 Jul;3:62-9. doi: 10.1007/s12975-012-0147-z. Epub 2012 Mar 15. PMID: 24323862.
Copy Download .nbib Format: NLM
Share it on

Transl Stroke Res. 2012 Jul;3:62-9. doi: 10.1007/s12975-012-0147-z. Epub 2012 Mar 15.

Excitatory and Mitogenic Signaling in Cell Death, Blood-brain Barrier Breakdown, and BBB Repair after Intracerebral Hemorrhage.

Translational stroke research

Da-Zhi Liu, Frank R Sharp

Affiliations

  1. Department of Neurology and M.I.N.D. Institute, University of California at Davis Medical Center, Sacramento, CA, 95817, USA, [email protected].

PMID: 24323862 DOI: 10.1007/s12975-012-0147-z

Abstract

Intracerebral hemorrhage (ICH) results in the release of a large number of endogenous molecules, including glutamate, Ca(2+), ROS, thrombin, heme, iron, TNF-α, and others. These molecules participate in excitatory and mitogenic signaling transduction in which N-methyl-D-aspartate (NMDA) receptors and Src family kinases (SFKs) are implicated. Mitogenic signaling initiates the cell cycle for normal cell division of microglia and neural progenitor cells, whereas aberrant mitogenic signaling causes toxicity, killing neurons, astrocytes, and brain microvascular endothelial cells in neurological diseases including ICH. In this review, we summarize (1) how SFKs modulate NMDA receptors to kill neurons following ICH and (2) how SFKs modulate mitogenic signaling transduction to kill neurons and play a role in disrupting the blood-brain barrier (BBB) immediately following ICH and in repairing the BBB during the recovery phases weeks following ICH.

References

  1. J Cereb Blood Flow Metab. 2000 Dec;20(12):1669-80 - PubMed
  2. J Biol Chem. 2011 Aug 26;286(34):29904-12 - PubMed
  3. J Comp Neurol. 2000 Oct 2;425(4):479-94 - PubMed
  4. Science. 1997 Jan 31;275(5300):674-8 - PubMed
  5. J Neurochem. 2001 Dec;79(5):950-8 - PubMed
  6. FASEB J. 1999 Dec;13(15):2225-34 - PubMed
  7. Nat Rev Neurosci. 2004 Apr;5(4):317-28 - PubMed
  8. J Neuropathol Exp Neurol. 2000 Oct;59(10):880-8 - PubMed
  9. J Biol Chem. 2009 Jan 30;284(5):3021-3027 - PubMed
  10. Stroke. 2004 Nov;35(11):2587-91 - PubMed
  11. J Neurosci. 2008 Oct 22;28(43):10786-93 - PubMed
  12. Neurosurg Focus. 2007 May 15;22(5):E6 - PubMed
  13. ScientificWorldJournal. 2012;2012:491737 - PubMed
  14. Apoptosis. 2009 Jul;14(7):900-12 - PubMed
  15. Cell. 2007 Jan 26;128(2):269-80 - PubMed
  16. FEBS J. 2012 Jan;279(1):20-8 - PubMed
  17. Annu Rev Neurosci. 2007;30:235-58 - PubMed
  18. J Neurosci. 1998 Oct 1;18(19):7768-78 - PubMed
  19. Curr Biol. 2006 Feb 7;16(3):230-41 - PubMed
  20. Acta Neurochir Suppl. 2008;105:43-6 - PubMed
  21. Curr Opin Genet Dev. 1993 Feb;3(1):26-34 - PubMed
  22. Cell Death Differ. 2007 Feb;14(2):240-53 - PubMed
  23. Clin Exp Pharmacol Physiol. 2012 Aug;39(8):684-91 - PubMed
  24. Mol Pharmacol. 2005 Jun;67(6):2049-56 - PubMed
  25. Int J Biochem Cell Biol. 2008;40(5):1055-64 - PubMed
  26. Exp Neurol. 2007 Jul;206(1):43-52 - PubMed
  27. Neurobiol Dis. 2010 Mar;37(3):549-57 - PubMed
  28. J Biol Chem. 2007 Feb 23;282(8):5327-39 - PubMed
  29. Neurobiol Dis. 2008 May;30(2):201-11 - PubMed
  30. Biol Chem. 2003 Feb;384(2):193-202 - PubMed
  31. Ann Neurol. 2010 Apr;67(4):526-33 - PubMed
  32. Acta Neurochir Suppl. 2011;111:77-81 - PubMed
  33. Proc Natl Acad Sci U S A. 2011 Aug 16;108(33):13782-7 - PubMed
  34. Biochem J. 2005 Dec 1;392(Pt 2):389-97 - PubMed
  35. J Neuroinflammation. 2008 Jan 18;5:4 - PubMed
  36. J Neurosci. 2002 Jan 1;22(1):10-20 - PubMed
  37. Breast Cancer Res. 2000;2(3):203-10 - PubMed
  38. Brain Res Bull. 2009 Mar 30;78(6):328-34 - PubMed
  39. J Clin Endocrinol Metab. 2004 Jul;89(7):3503-9 - PubMed
  40. Proc Natl Acad Sci U S A. 1999 Aug 17;96(17):9557-62 - PubMed
  41. Stroke. 2007 May;38(5):1621-5 - PubMed
  42. J Neurosurg. 2007 Feb;106(2):314-20 - PubMed
  43. Am J Physiol Heart Circ Physiol. 2006 May;290(5):H1740-6 - PubMed
  44. J Neuroimmune Pharmacol. 2006 Sep;1(3):223-36 - PubMed
  45. J Biol Chem. 2011 Jun 10;286(23):20175-93 - PubMed
  46. J Neurovirol. 2007 Aug;13(4):373-83 - PubMed
  47. J Biol Chem. 2006 Feb 24;281(8):4771-8 - PubMed
  48. J Neurosci. 2002 Jul 1;22(13):5452-61 - PubMed
  49. J Neurochem. 2004 Nov;91(3):667-82 - PubMed
  50. J Pharmacol Exp Ther. 1999 Nov;291(2):688-704 - PubMed
  51. FEBS J. 2012 Jan;279(1):12-9 - PubMed
  52. J Neurosci. 2006 Dec 13;26(50):13007-16 - PubMed
  53. Lancet Neurol. 2009 Feb;8(2):205-16 - PubMed

Publication Types